Results 241 to 250 of about 99,629 (284)

First-in-Human Study of ¹⁸F-Labeled PET Tracer for Glutamate AMPA Receptor [¹⁸F]K-40: A Derivative of [¹¹C]K-2. [PDF]

J Nucl Med
Ichijo S, Arisawa T, Hatano M, Nakajima W, Miyazaki T, Eiro T, Takada Y, Iai R, Sano A, Sonoda M, Takayama Y, Kimura Y, Takahashi T.   +12 more
europepmc   +1 more source

Calcium binding proteins and the AMPA glutamate receptor subunits in gerbil cochlear nucleus

, 2000
Sailaja Korada, Ilsa R. Schwartz
openalex   +1 more source

Corrigendum: α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor density underlies intraregional and interregional functional centrality. [PDF]

Front Neural Circuits
Yatomi T, Tomasi D, Tani H, Nakajima S, Tsugawa S, Nagai N, Koizumi T, Nakajima W, Hatano M, Uchida H, Takahashi T.   +10 more
europepmc   +1 more source

NMDA and AMPA/Kainate Glutamate Receptors Modulate Dentate Neurogenesis and CA3 Synapsin-I in Normal and Ischemic Hippocampus

, 2000
Ramón Bernabeu, Frank R. Sharp
openalex   +1 more source

Cadmium opens GluK2 kainate receptors with cysteine substitutions at the M3 helix bundle crossing [PDF]

, 2019
Huettner, James E, Wilding, Timothy J
core   +1 more source

SHP2 regulates GluA2 tyrosine phosphorylation required for AMPA receptor endocytosis and mGluR-LTD. [PDF]

Proc Natl Acad Sci U S A
Lee S, Kim J, Ryu HH, Jang H, Lee D, Lee S, Song JM, Lee YS, Suh YH.   +8 more
europepmc   +1 more source

Assessing the Effects of Thiazole-Carboxamide Derivatives on the Biophysical Properties of AMPA Receptor Complexes as a Potential Neuroprotective Agent. [PDF]

Molecules
Qneibi M, Hawash M, Bdir S, Bdair M, Aldwaik SA.   +4 more
europepmc   +1 more source

GABAergic synaptic scaling is triggered by changes in spiking activity rather than AMPA receptor activation. [PDF]

Elife
Gonzalez-Islas C, Sabra Z, Fong MF, Yilmam P, Au Yong N, Engisch K, Wenner P.   +6 more
europepmc   +1 more source

Ethanol self-administration targets GluA2-containing AMPA receptor expression and synaptic activity in the nucleus accumbens in a manner that drives the positive reinforcing properties of the drug. [PDF]

Psychopharmacology (Berl)
Faccidomo S, Saunders BL, May AM, Eastman VR, Kim M, Taylor SM, Hoffman JL, McElligott ZA, Hodge CW.   +8 more
europepmc   +1 more source